HEADER TRANSFERASE 15-JUL-09 3IBE TITLE CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR BOUND TO PI3 TITLE 2 KINASE GAMMA COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC COMPND 3 SUBUNIT GAMMA ISOFORM; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: PI3 KINASE GAMMA (UNP RESIDUES 144 TO 1102); COMPND 6 SYNONYM: PI3-KINASE P110 SUBUNIT GAMMA, PTDINS-3-KINASE SUBUNIT P110, COMPND 7 PI3KGAMMA, PI3K, P120-PI3K; COMPND 8 EC: 2.7.1.153; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PIK3CG; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PI3KINASE INHIBITOR, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.BARD,K.SVENSON REVDAT 3 06-SEP-23 3IBE 1 REMARK SEQADV REVDAT 2 01-NOV-17 3IBE 1 REMARK REVDAT 1 01-SEP-09 3IBE 0 JRNL AUTH A.ZASK,J.C.VERHEIJEN,K.CURRAN,J.KAPLAN,D.J.RICHARD,P.NOWAK, JRNL AUTH 2 D.J.MALWITZ,N.BROOIJMANS,J.BARD,K.SVENSON,J.LUCAS, JRNL AUTH 3 L.TORAL-BARZA,W.G.ZHANG,I.HOLLANDER,J.J.GIBBONS,R.T.ABRAHAM, JRNL AUTH 4 S.AYRAL-KALOUSTIAN,T.S.MANSOUR,K.YU JRNL TITL ATP-COMPETITIVE INHIBITORS OF THE MAMMALIAN TARGET OF JRNL TITL 2 RAPAMYCIN: DESIGN AND SYNTHESIS OF HIGHLY POTENT AND JRNL TITL 3 SELECTIVE PYRAZOLOPYRIMIDINES. JRNL REF J.MED.CHEM. V. 52 5013 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19645448 JRNL DOI 10.1021/JM900851F REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.71 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.150 REMARK 3 COMPLETENESS FOR RANGE (%) : 83.1 REMARK 3 NUMBER OF REFLECTIONS : 21693 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.150 REMARK 3 FREE R VALUE TEST SET COUNT : 1117 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.7170 - 5.5920 0.99 3175 167 0.2100 0.2580 REMARK 3 2 5.5920 - 4.4400 0.99 3074 167 0.1680 0.2350 REMARK 3 3 4.4400 - 3.8790 0.98 3050 155 0.1740 0.2470 REMARK 3 4 3.8790 - 3.5250 0.97 2984 160 0.1990 0.2790 REMARK 3 5 3.5250 - 3.2720 0.93 2853 154 0.2460 0.3260 REMARK 3 6 3.2720 - 3.0790 0.80 2435 128 0.2670 0.3860 REMARK 3 7 3.0790 - 2.9250 0.59 1824 103 0.2770 0.3630 REMARK 3 8 2.9250 - 2.7980 0.39 1181 83 0.2920 0.4320 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.29 REMARK 3 B_SOL : 55.21 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.410 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 70.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.62700 REMARK 3 B22 (A**2) : 15.39800 REMARK 3 B33 (A**2) : 5.01500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 12.67100 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 6727 REMARK 3 ANGLE : 1.356 9158 REMARK 3 CHIRALITY : 0.066 1055 REMARK 3 PLANARITY : 0.006 1165 REMARK 3 DIHEDRAL : 18.563 2345 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3IBE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JUL-09. REMARK 100 THE DEPOSITION ID IS D_1000054201. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-OCT-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23209 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.1 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.08400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 48.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.43300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX RIGID BODY REMARK 200 STARTING MODEL: PDB ENTRY 1E8Y REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS PH 8.3, 100 MM AMMONIUM REMARK 280 SULFATE, 17% PEG 3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 72.57950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.22900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 72.57950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.22900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 253 REMARK 465 LYS A 254 REMARK 465 LYS A 255 REMARK 465 LYS A 256 REMARK 465 SER A 257 REMARK 465 LEU A 258 REMARK 465 MET A 259 REMARK 465 ASP A 260 REMARK 465 ILE A 261 REMARK 465 PRO A 262 REMARK 465 GLU A 263 REMARK 465 SER A 264 REMARK 465 GLN A 265 REMARK 465 SER A 266 REMARK 465 PRO A 324 REMARK 465 LEU A 325 REMARK 465 VAL A 326 REMARK 465 ASP A 327 REMARK 465 ASP A 328 REMARK 465 CYS A 329 REMARK 465 THR A 330 REMARK 465 GLY A 331 REMARK 465 VAL A 332 REMARK 465 THR A 333 REMARK 465 GLY A 334 REMARK 465 TYR A 335 REMARK 465 HIS A 336 REMARK 465 GLU A 337 REMARK 465 GLN A 338 REMARK 465 LEU A 339 REMARK 465 THR A 340 REMARK 465 ILE A 341 REMARK 465 HIS A 342 REMARK 465 GLY A 343 REMARK 465 LYS A 344 REMARK 465 ASP A 345 REMARK 465 HIS A 346 REMARK 465 GLU A 347 REMARK 465 SER A 348 REMARK 465 VAL A 349 REMARK 465 PHE A 350 REMARK 465 THR A 351 REMARK 465 VAL A 352 REMARK 465 SER A 353 REMARK 465 PRO A 374 REMARK 465 ARG A 375 REMARK 465 ASN A 376 REMARK 465 THR A 377 REMARK 465 LYS A 437 REMARK 465 ALA A 438 REMARK 465 PRO A 439 REMARK 465 ALA A 440 REMARK 465 LEU A 441 REMARK 465 SER A 442 REMARK 465 SER A 443 REMARK 465 LYS A 444 REMARK 465 ALA A 445 REMARK 465 SER A 446 REMARK 465 ALA A 447 REMARK 465 GLU A 448 REMARK 465 SER A 449 REMARK 465 PRO A 450 REMARK 465 SER A 451 REMARK 465 SER A 452 REMARK 465 GLU A 453 REMARK 465 SER A 454 REMARK 465 LYS A 455 REMARK 465 GLY A 456 REMARK 465 LYS A 457 REMARK 465 GLY A 489 REMARK 465 LYS A 490 REMARK 465 GLY A 491 REMARK 465 GLU A 492 REMARK 465 ASP A 493 REMARK 465 GLN A 494 REMARK 465 GLY A 495 REMARK 465 TYR A 523 REMARK 465 CYS A 524 REMARK 465 PRO A 536 REMARK 465 ASP A 537 REMARK 465 PRO A 538 REMARK 465 GLU A 539 REMARK 465 GLY A 540 REMARK 465 THR A 895 REMARK 465 VAL A 896 REMARK 465 GLY A 897 REMARK 465 ASN A 898 REMARK 465 ILE A 968 REMARK 465 LEU A 969 REMARK 465 GLY A 970 REMARK 465 ASN A 971 REMARK 465 TYR A 972 REMARK 465 LYS A 973 REMARK 465 SER A 974 REMARK 465 PHE A 975 REMARK 465 LEU A 976 REMARK 465 GLY A 977 REMARK 465 ILE A 978 REMARK 465 ASN A 979 REMARK 465 GLN A 1041 REMARK 465 GLY A 1093 REMARK 465 ILE A 1094 REMARK 465 LYS A 1095 REMARK 465 GLN A 1096 REMARK 465 GLY A 1097 REMARK 465 GLU A 1098 REMARK 465 LYS A 1099 REMARK 465 HIS A 1100 REMARK 465 SER A 1101 REMARK 465 ALA A 1102 REMARK 465 HIS A 1103 REMARK 465 HIS A 1104 REMARK 465 HIS A 1105 REMARK 465 HIS A 1106 REMARK 465 HIS A 1107 REMARK 465 HIS A 1108 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 143 CG SD CE REMARK 470 GLU A 146 CG CD OE1 OE2 REMARK 470 GLN A 148 CG CD OE1 NE2 REMARK 470 ARG A 152 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 178 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 213 CG CD CE NZ REMARK 470 LYS A 214 CG CD CE NZ REMARK 470 ILE A 215 CG1 CG2 CD1 REMARK 470 ASN A 217 CG OD1 ND2 REMARK 470 ILE A 220 CG1 CG2 CD1 REMARK 470 GLN A 231 CG CD OE1 NE2 REMARK 470 LYS A 251 CG CD CE NZ REMARK 470 MET A 252 CG SD CE REMARK 470 GLU A 267 CG CD OE1 OE2 REMARK 470 GLN A 268 CG CD OE1 NE2 REMARK 470 LEU A 307 CG CD1 CD2 REMARK 470 LYS A 320 CG CD CE NZ REMARK 470 TRP A 323 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 323 CZ3 CH2 REMARK 470 LEU A 354 CG CD1 CD2 REMARK 470 ARG A 359 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 364 CG CD CE NZ REMARK 470 LEU A 373 CG CD1 CD2 REMARK 470 ASP A 378 CG OD1 OD2 REMARK 470 ARG A 398 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 406 CG CD OE1 OE2 REMARK 470 LYS A 419 CG CD CE NZ REMARK 470 LYS A 421 CG CD CE NZ REMARK 470 ARG A 459 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 461 CG CD1 CD2 REMARK 470 ARG A 477 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 486 CG CD OE1 NE2 REMARK 470 PHE A 497 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 511 CG CD OE1 OE2 REMARK 470 ASN A 522 CG OD1 ND2 REMARK 470 HIS A 525 CG ND1 CD2 CE1 NE2 REMARK 470 LEU A 529 CG CD1 CD2 REMARK 470 LYS A 531 CG CD CE NZ REMARK 470 HIS A 532 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 533 CG CD OE1 NE2 REMARK 470 THR A 535 OG1 CG2 REMARK 470 ASP A 541 CG OD1 OD2 REMARK 470 ARG A 542 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 544 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 546 CG CD OE1 OE2 REMARK 470 GLU A 581 CG CD OE1 OE2 REMARK 470 GLU A 602 CG CD OE1 OE2 REMARK 470 ARG A 613 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 615 CG CD OE1 OE2 REMARK 470 GLU A 638 CG CD OE1 OE2 REMARK 470 GLN A 743 CG CD OE1 NE2 REMARK 470 LYS A 744 CG CD CE NZ REMARK 470 LYS A 750 CG CD CE NZ REMARK 470 GLU A 755 CG CD OE1 OE2 REMARK 470 LYS A 756 CG CD CE NZ REMARK 470 TYR A 757 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 VAL A 759 CG1 CG2 REMARK 470 GLN A 762 CG CD OE1 NE2 REMARK 470 GLN A 766 CG CD OE1 NE2 REMARK 470 LEU A 767 CG CD1 CD2 REMARK 470 LYS A 768 CG CD CE NZ REMARK 470 GLN A 769 CG CD OE1 NE2 REMARK 470 LYS A 770 CG CD CE NZ REMARK 470 GLU A 772 CG CD OE1 OE2 REMARK 470 ASN A 773 CG OD1 ND2 REMARK 470 LEU A 774 CG CD1 CD2 REMARK 470 GLN A 775 CG CD OE1 NE2 REMARK 470 ASN A 776 CG OD1 ND2 REMARK 470 GLN A 778 CG CD OE1 NE2 REMARK 470 LEU A 779 CG CD1 CD2 REMARK 470 GLU A 781 CG CD OE1 OE2 REMARK 470 LYS A 808 CG CD CE NZ REMARK 470 LYS A 816 CG CD CE NZ REMARK 470 LEU A 823 CG CD1 CD2 REMARK 470 SER A 824 OG REMARK 470 GLU A 826 CG CD OE1 OE2 REMARK 470 LYS A 890 CG CD CE NZ REMARK 470 THR A 899 OG1 CG2 REMARK 470 LYS A 903 CG CD CE NZ REMARK 470 LEU A 907 CG CD1 CD2 REMARK 470 LEU A 911 CG CD1 CD2 REMARK 470 LYS A 912 CG CD CE NZ REMARK 470 GLU A 926 CG CD OE1 OE2 REMARK 470 HIS A 967 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 980 CG CD CE NZ REMARK 470 GLU A 981 CG CD OE1 OE2 REMARK 470 ARG A 982 CG CD NE CZ NH1 NH2 REMARK 470 LYS A1000 CG CD CE NZ REMARK 470 LYS A1001 CG CD CE NZ REMARK 470 GLN A1007 CG CD OE1 NE2 REMARK 470 LEU A1042 CG CD1 CD2 REMARK 470 LYS A1045 CG CD CE NZ REMARK 470 GLU A1046 CG CD OE1 OE2 REMARK 470 LYS A1065 CG CD CE NZ REMARK 470 LYS A1066 CG CD CE NZ REMARK 470 LYS A1078 CG CD CE NZ REMARK 470 LEU A1092 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O THR A 1081 OD1 ASN A 1085 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 810 C - N - CA ANGL. DEV. = 10.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 144 22.39 -71.00 REMARK 500 VAL A 162 11.73 -65.36 REMARK 500 ASN A 167 43.10 -145.57 REMARK 500 HIS A 199 45.46 31.72 REMARK 500 ILE A 215 -71.19 -49.05 REMARK 500 ALA A 216 49.02 86.08 REMARK 500 SER A 227 -74.01 -125.22 REMARK 500 SER A 230 135.39 -179.18 REMARK 500 THR A 232 150.75 -40.03 REMARK 500 ASP A 269 54.43 -94.63 REMARK 500 LEU A 272 97.33 -69.07 REMARK 500 ASP A 278 51.07 -99.14 REMARK 500 LEU A 281 75.94 -101.01 REMARK 500 ILE A 303 78.73 -52.25 REMARK 500 ARG A 366 -74.58 -69.08 REMARK 500 PRO A 371 -157.99 -54.04 REMARK 500 VAL A 372 108.52 -25.67 REMARK 500 LEU A 379 -176.31 165.10 REMARK 500 GLN A 391 -20.22 76.73 REMARK 500 TRP A 410 -46.13 -156.68 REMARK 500 ASN A 411 6.35 51.54 REMARK 500 LYS A 419 158.51 -44.84 REMARK 500 PHE A 473 -6.01 73.96 REMARK 500 LYS A 531 108.98 -57.59 REMARK 500 HIS A 532 155.11 -39.42 REMARK 500 PRO A 548 162.95 -48.76 REMARK 500 LEU A 555 -70.71 -53.57 REMARK 500 LEU A 611 -5.70 -59.84 REMARK 500 GLU A 638 -49.55 -21.09 REMARK 500 LYS A 683 -71.16 -60.26 REMARK 500 ARG A 690 -76.95 -75.10 REMARK 500 ILE A 691 -45.39 -21.81 REMARK 500 TYR A 757 153.28 -48.55 REMARK 500 ASP A 758 -151.31 -95.84 REMARK 500 SER A 777 -78.99 -158.70 REMARK 500 ASP A 788 73.53 -171.81 REMARK 500 ALA A 797 73.32 -104.72 REMARK 500 SER A 806 151.41 -37.92 REMARK 500 LYS A 809 83.84 45.12 REMARK 500 GLU A 814 135.69 -175.08 REMARK 500 ALA A 818 -11.21 -45.31 REMARK 500 LEU A 823 -73.43 -54.58 REMARK 500 SER A 824 -168.37 -77.22 REMARK 500 GLU A 826 142.73 -37.96 REMARK 500 PHE A 832 109.36 -55.58 REMARK 500 SER A 859 70.58 56.16 REMARK 500 CYS A 869 108.79 -161.05 REMARK 500 THR A 887 -178.96 -67.74 REMARK 500 LEU A 907 -72.01 -48.95 REMARK 500 TYR A 935 -6.70 -56.55 REMARK 500 REMARK 500 THIS ENTRY HAS 65 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L64 A 1109 DBREF 3IBE A 144 1102 UNP P48736 PK3CG_HUMAN 144 1102 SEQADV 3IBE MET A 143 UNP P48736 EXPRESSION TAG SEQADV 3IBE ARG A 459 UNP P48736 GLN 459 VARIANT SEQADV 3IBE HIS A 1103 UNP P48736 EXPRESSION TAG SEQADV 3IBE HIS A 1104 UNP P48736 EXPRESSION TAG SEQADV 3IBE HIS A 1105 UNP P48736 EXPRESSION TAG SEQADV 3IBE HIS A 1106 UNP P48736 EXPRESSION TAG SEQADV 3IBE HIS A 1107 UNP P48736 EXPRESSION TAG SEQADV 3IBE HIS A 1108 UNP P48736 EXPRESSION TAG SEQRES 1 A 966 MET SER GLU GLU SER GLN ALA PHE GLN ARG GLN LEU THR SEQRES 2 A 966 ALA LEU ILE GLY TYR ASP VAL THR ASP VAL SER ASN VAL SEQRES 3 A 966 HIS ASP ASP GLU LEU GLU PHE THR ARG ARG GLY LEU VAL SEQRES 4 A 966 THR PRO ARG MET ALA GLU VAL ALA SER ARG ASP PRO LYS SEQRES 5 A 966 LEU TYR ALA MET HIS PRO TRP VAL THR SER LYS PRO LEU SEQRES 6 A 966 PRO GLU TYR LEU TRP LYS LYS ILE ALA ASN ASN CYS ILE SEQRES 7 A 966 PHE ILE VAL ILE HIS ARG SER THR THR SER GLN THR ILE SEQRES 8 A 966 LYS VAL SER PRO ASP ASP THR PRO GLY ALA ILE LEU GLN SEQRES 9 A 966 SER PHE PHE THR LYS MET ALA LYS LYS LYS SER LEU MET SEQRES 10 A 966 ASP ILE PRO GLU SER GLN SER GLU GLN ASP PHE VAL LEU SEQRES 11 A 966 ARG VAL CYS GLY ARG ASP GLU TYR LEU VAL GLY GLU THR SEQRES 12 A 966 PRO ILE LYS ASN PHE GLN TRP VAL ARG HIS CYS LEU LYS SEQRES 13 A 966 ASN GLY GLU GLU ILE HIS VAL VAL LEU ASP THR PRO PRO SEQRES 14 A 966 ASP PRO ALA LEU ASP GLU VAL ARG LYS GLU GLU TRP PRO SEQRES 15 A 966 LEU VAL ASP ASP CYS THR GLY VAL THR GLY TYR HIS GLU SEQRES 16 A 966 GLN LEU THR ILE HIS GLY LYS ASP HIS GLU SER VAL PHE SEQRES 17 A 966 THR VAL SER LEU TRP ASP CYS ASP ARG LYS PHE ARG VAL SEQRES 18 A 966 LYS ILE ARG GLY ILE ASP ILE PRO VAL LEU PRO ARG ASN SEQRES 19 A 966 THR ASP LEU THR VAL PHE VAL GLU ALA ASN ILE GLN HIS SEQRES 20 A 966 GLY GLN GLN VAL LEU CYS GLN ARG ARG THR SER PRO LYS SEQRES 21 A 966 PRO PHE THR GLU GLU VAL LEU TRP ASN VAL TRP LEU GLU SEQRES 22 A 966 PHE SER ILE LYS ILE LYS ASP LEU PRO LYS GLY ALA LEU SEQRES 23 A 966 LEU ASN LEU GLN ILE TYR CYS GLY LYS ALA PRO ALA LEU SEQRES 24 A 966 SER SER LYS ALA SER ALA GLU SER PRO SER SER GLU SER SEQRES 25 A 966 LYS GLY LYS VAL ARG LEU LEU TYR TYR VAL ASN LEU LEU SEQRES 26 A 966 LEU ILE ASP HIS ARG PHE LEU LEU ARG ARG GLY GLU TYR SEQRES 27 A 966 VAL LEU HIS MET TRP GLN ILE SER GLY LYS GLY GLU ASP SEQRES 28 A 966 GLN GLY SER PHE ASN ALA ASP LYS LEU THR SER ALA THR SEQRES 29 A 966 ASN PRO ASP LYS GLU ASN SER MET SER ILE SER ILE LEU SEQRES 30 A 966 LEU ASP ASN TYR CYS HIS PRO ILE ALA LEU PRO LYS HIS SEQRES 31 A 966 GLN PRO THR PRO ASP PRO GLU GLY ASP ARG VAL ARG ALA SEQRES 32 A 966 GLU MET PRO ASN GLN LEU ARG LYS GLN LEU GLU ALA ILE SEQRES 33 A 966 ILE ALA THR ASP PRO LEU ASN PRO LEU THR ALA GLU ASP SEQRES 34 A 966 LYS GLU LEU LEU TRP HIS PHE ARG TYR GLU SER LEU LYS SEQRES 35 A 966 HIS PRO LYS ALA TYR PRO LYS LEU PHE SER SER VAL LYS SEQRES 36 A 966 TRP GLY GLN GLN GLU ILE VAL ALA LYS THR TYR GLN LEU SEQRES 37 A 966 LEU ALA ARG ARG GLU VAL TRP ASP GLN SER ALA LEU ASP SEQRES 38 A 966 VAL GLY LEU THR MET GLN LEU LEU ASP CYS ASN PHE SER SEQRES 39 A 966 ASP GLU ASN VAL ARG ALA ILE ALA VAL GLN LYS LEU GLU SEQRES 40 A 966 SER LEU GLU ASP ASP ASP VAL LEU HIS TYR LEU LEU GLN SEQRES 41 A 966 LEU VAL GLN ALA VAL LYS PHE GLU PRO TYR HIS ASP SER SEQRES 42 A 966 ALA LEU ALA ARG PHE LEU LEU LYS ARG GLY LEU ARG ASN SEQRES 43 A 966 LYS ARG ILE GLY HIS PHE LEU PHE TRP PHE LEU ARG SER SEQRES 44 A 966 GLU ILE ALA GLN SER ARG HIS TYR GLN GLN ARG PHE ALA SEQRES 45 A 966 VAL ILE LEU GLU ALA TYR LEU ARG GLY CYS GLY THR ALA SEQRES 46 A 966 MET LEU HIS ASP PHE THR GLN GLN VAL GLN VAL ILE GLU SEQRES 47 A 966 MET LEU GLN LYS VAL THR LEU ASP ILE LYS SER LEU SER SEQRES 48 A 966 ALA GLU LYS TYR ASP VAL SER SER GLN VAL ILE SER GLN SEQRES 49 A 966 LEU LYS GLN LYS LEU GLU ASN LEU GLN ASN SER GLN LEU SEQRES 50 A 966 PRO GLU SER PHE ARG VAL PRO TYR ASP PRO GLY LEU LYS SEQRES 51 A 966 ALA GLY ALA LEU ALA ILE GLU LYS CYS LYS VAL MET ALA SEQRES 52 A 966 SER LYS LYS LYS PRO LEU TRP LEU GLU PHE LYS CYS ALA SEQRES 53 A 966 ASP PRO THR ALA LEU SER ASN GLU THR ILE GLY ILE ILE SEQRES 54 A 966 PHE LYS HIS GLY ASP ASP LEU ARG GLN ASP MET LEU ILE SEQRES 55 A 966 LEU GLN ILE LEU ARG ILE MET GLU SER ILE TRP GLU THR SEQRES 56 A 966 GLU SER LEU ASP LEU CYS LEU LEU PRO TYR GLY CYS ILE SEQRES 57 A 966 SER THR GLY ASP LYS ILE GLY MET ILE GLU ILE VAL LYS SEQRES 58 A 966 ASP ALA THR THR ILE ALA LYS ILE GLN GLN SER THR VAL SEQRES 59 A 966 GLY ASN THR GLY ALA PHE LYS ASP GLU VAL LEU ASN HIS SEQRES 60 A 966 TRP LEU LYS GLU LYS SER PRO THR GLU GLU LYS PHE GLN SEQRES 61 A 966 ALA ALA VAL GLU ARG PHE VAL TYR SER CYS ALA GLY TYR SEQRES 62 A 966 CYS VAL ALA THR PHE VAL LEU GLY ILE GLY ASP ARG HIS SEQRES 63 A 966 ASN ASP ASN ILE MET ILE THR GLU THR GLY ASN LEU PHE SEQRES 64 A 966 HIS ILE ASP PHE GLY HIS ILE LEU GLY ASN TYR LYS SER SEQRES 65 A 966 PHE LEU GLY ILE ASN LYS GLU ARG VAL PRO PHE VAL LEU SEQRES 66 A 966 THR PRO ASP PHE LEU PHE VAL MET GLY THR SER GLY LYS SEQRES 67 A 966 LYS THR SER PRO HIS PHE GLN LYS PHE GLN ASP ILE CYS SEQRES 68 A 966 VAL LYS ALA TYR LEU ALA LEU ARG HIS HIS THR ASN LEU SEQRES 69 A 966 LEU ILE ILE LEU PHE SER MET MET LEU MET THR GLY MET SEQRES 70 A 966 PRO GLN LEU THR SER LYS GLU ASP ILE GLU TYR ILE ARG SEQRES 71 A 966 ASP ALA LEU THR VAL GLY LYS ASN GLU GLU ASP ALA LYS SEQRES 72 A 966 LYS TYR PHE LEU ASP GLN ILE GLU VAL CYS ARG ASP LYS SEQRES 73 A 966 GLY TRP THR VAL GLN PHE ASN TRP PHE LEU HIS LEU VAL SEQRES 74 A 966 LEU GLY ILE LYS GLN GLY GLU LYS HIS SER ALA HIS HIS SEQRES 75 A 966 HIS HIS HIS HIS HET SO4 A 1 5 HET L64 A1109 45 HETNAM SO4 SULFATE ION HETNAM L64 1-(4-{4-MORPHOLIN-4-YL-1-[1-(PYRIDIN-3-YLCARBONYL) HETNAM 2 L64 PIPERIDIN-4-YL]-1H-PYRAZOLO[3,4-D]PYRIMIDIN-6- HETNAM 3 L64 YL}PHENYL)-3-PYRIDIN-4-YLUREA FORMUL 2 SO4 O4 S 2- FORMUL 3 L64 C32 H32 N10 O3 FORMUL 4 HOH *42(H2 O) HELIX 1 1 ALA A 149 GLY A 159 1 11 HELIX 2 2 ASP A 171 LEU A 180 1 10 HELIX 3 3 LEU A 180 ARG A 191 1 12 HELIX 4 4 ASP A 192 HIS A 199 1 8 HELIX 5 5 PRO A 208 LYS A 213 1 6 HELIX 6 6 PRO A 241 THR A 250 1 10 HELIX 7 7 PRO A 286 ASN A 289 5 4 HELIX 8 8 PHE A 290 ASN A 299 1 10 HELIX 9 9 ASP A 312 ASP A 316 5 5 HELIX 10 10 ASN A 498 THR A 503 5 6 HELIX 11 11 PRO A 548 ILE A 559 1 12 HELIX 12 12 THR A 568 PHE A 578 1 11 HELIX 13 13 PHE A 578 LEU A 583 1 6 HELIX 14 14 HIS A 585 LYS A 587 5 3 HELIX 15 15 ALA A 588 PHE A 593 1 6 HELIX 16 16 GLN A 600 GLN A 609 1 10 HELIX 17 17 LEU A 610 ARG A 613 5 4 HELIX 18 18 ARG A 614 SER A 620 1 7 HELIX 19 19 ASP A 623 LEU A 630 1 8 HELIX 20 20 ASP A 637 GLU A 649 1 13 HELIX 21 21 GLU A 652 ALA A 666 1 15 HELIX 22 22 VAL A 667 PHE A 669 5 3 HELIX 23 23 SER A 675 ASN A 688 1 14 HELIX 24 24 ASN A 688 ALA A 704 1 17 HELIX 25 25 TYR A 709 ARG A 722 1 14 HELIX 26 26 GLY A 725 SER A 751 1 27 HELIX 27 27 SER A 760 ASN A 776 1 17 HELIX 28 28 ILE A 798 CYS A 801 5 4 HELIX 29 29 LEU A 838 TRP A 855 1 18 HELIX 30 30 ILE A 888 GLN A 893 1 6 HELIX 31 31 GLU A 905 LYS A 914 1 10 HELIX 32 32 GLU A 919 LEU A 942 1 24 HELIX 33 33 THR A 988 GLY A 996 1 9 HELIX 34 34 HIS A 1005 HIS A 1023 1 19 HELIX 35 35 HIS A 1023 MET A 1039 1 17 HELIX 36 36 ILE A 1048 LEU A 1055 1 8 HELIX 37 37 ASN A 1060 CYS A 1075 1 16 HELIX 38 38 TRP A 1080 HIS A 1089 1 10 SHEET 1 A 2 ILE A 220 PHE A 221 0 SHEET 2 A 2 LYS A 234 VAL A 235 -1 O VAL A 235 N ILE A 220 SHEET 1 B 4 VAL A 223 ILE A 224 0 SHEET 2 B 4 HIS A 304 ASP A 308 1 O VAL A 305 N VAL A 223 SHEET 3 B 4 VAL A 271 VAL A 274 -1 N ARG A 273 O VAL A 306 SHEET 4 B 4 TYR A 280 LEU A 281 -1 O LEU A 281 N LEU A 272 SHEET 1 C 4 GLU A 407 LYS A 419 0 SHEET 2 C 4 LYS A 360 ASP A 369 -1 N ILE A 368 O VAL A 408 SHEET 3 C 4 SER A 517 LEU A 520 -1 O LEU A 519 N LYS A 364 SHEET 4 C 4 GLY A 478 VAL A 481 -1 N GLY A 478 O LEU A 520 SHEET 1 D 5 GLN A 392 ARG A 397 0 SHEET 2 D 5 THR A 380 HIS A 389 -1 N ILE A 387 O CYS A 395 SHEET 3 D 5 LEU A 428 GLY A 436 -1 O ASN A 430 N ASN A 386 SHEET 4 D 5 ARG A 459 LEU A 467 -1 O LEU A 466 N LEU A 429 SHEET 5 D 5 TRP A 485 GLN A 486 -1 O TRP A 485 N TYR A 463 SHEET 1 E 3 PHE A 783 ARG A 784 0 SHEET 2 E 3 LYS A 792 LEU A 796 -1 O ALA A 793 N PHE A 783 SHEET 3 E 3 PHE A 815 CYS A 817 -1 O LYS A 816 N ALA A 795 SHEET 1 F 5 LYS A 802 VAL A 803 0 SHEET 2 F 5 LEU A 811 TRP A 812 -1 O TRP A 812 N LYS A 802 SHEET 3 F 5 ILE A 831 HIS A 834 -1 O PHE A 832 N LEU A 811 SHEET 4 F 5 ILE A 876 ILE A 879 -1 O ILE A 879 N ILE A 831 SHEET 5 F 5 CYS A 869 SER A 871 -1 N ILE A 870 O MET A 878 SHEET 1 G 3 ALA A 885 THR A 887 0 SHEET 2 G 3 ILE A 952 THR A 955 -1 O ILE A 954 N THR A 886 SHEET 3 G 3 LEU A 960 HIS A 962 -1 O PHE A 961 N MET A 953 SITE 1 AC1 4 PRO A 206 LEU A 207 TRP A 212 LYS A 288 SITE 1 AC2 18 MET A 804 ALA A 805 SER A 806 ILE A 831 SITE 2 AC2 18 LYS A 833 ASP A 836 ASP A 837 LEU A 838 SITE 3 AC2 18 GLN A 840 ASP A 841 ILE A 879 GLU A 880 SITE 4 AC2 18 ILE A 881 VAL A 882 ASP A 950 MET A 953 SITE 5 AC2 18 ASP A 964 GLY A 966 CRYST1 145.159 68.458 106.901 90.00 94.80 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006889 0.000000 0.000578 0.00000 SCALE2 0.000000 0.014607 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009387 0.00000